Drug Shortage & Pharmacy Stock Watch

Why this is recommended

A three-day head start on filling before a shortage hits, a documented alternative to ask a doctor about, or an FDA import allowance that opens supply each keeps a treatment on schedule; the fee is beside the point.

What the Tab covers

Who it is for

The 20 million Americans who take a drug that has been in shortage in the past year, including ADHD, diabetes, antibiotic, chemotherapy and injectable medications.

When it runs

FDA and ASHP update shortage lists daily, manufacturers announce resolutions with dates, and pharmacy allocations reset at the start of each month

Scope

FDA Drug Shortages database; ASHP shortage list; manufacturer notices from Teva, Sandoz, Pfizer, Hikma, Fresenius, Novo Nordisk, Lilly and others; FDA compounding and import guidance; CVS, Walgreens, Walmart and Costco pharmacy policies; GoodRx and NADAC price data

Suggested task

The objective your Tab starts with. You can edit every line of it once the Tab is yours.

New and resolved drug shortages with the affected strengths and expected resolution dates, manufacturer allocation and discontinuation notices, FDA import and compounding allowances, therapeutic alternative guidance, pharmacy chain stock and transfer policy changes, and price spikes on shortage drugs, with the drug and the status first.

Track drug shortages for US patients. Report only confirmed, source-backed items from the last 24 hours: new shortages added to the FDA or ASHP lists with affected drugs, strengths and forms; shortages marked resolved or with a manufacturer resolution date; manufacturer allocation, discontinuation and recall notices affecting supply; FDA temporary import, compounding or extended expiration allowances; published therapeutic alternative guidance from ASHP, FDA or specialty societies; pharmacy chain policy changes on transfers, partial fills and allocation at CVS, Walgreens, Walmart and Costco; and price increases over 25 percent on shortage drugs from NADAC or GoodRx data. Prefer FDA, ASHP, manufacturer and pharmacy chain sources; ignore anecdotal availability reports. Put the drug and the status first in the title. Use high severity for a new shortage of a drug with over 1 million monthly prescriptions, a discontinuation, or a shortage in an oncology or emergency medicine. Return no more than 8 findings. Push each as a finding with a title, a two-sentence summary, sections for what is affected, the expected duration, alternatives to discuss with a prescriber, what to ask the pharmacy, and the source link. If nothing qualifies, push nothing and submit the run receipt.